Endotoxin-induced and vaccine-induced systemic inflammation both impair endothelium-dependent vasodilation, but not pulse wave reflection

Vascular Health and Risk Management

Volumn 8, Issue 1, 2012, Pages 447-453

  Lind, Lars ^a   Hulthe, Johannes ^b,c   Johansson, Annika ^c   Hedner, Ewa ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Endothelium; Endotoxin; Inflammation; Vaccination; Vasodilation

Indexed keywords

ACETYLCHOLINE; ESCHERICHIA COLI ENDOTOXIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; NITROPRUSSIDE SODIUM; TYPHOID VACCINE; AUTACOID; BIOLOGICAL MARKER; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; IL6 PROTEIN, HUMAN; SALMONELLOSIS VACCINE; VASODILATOR AGENT;

ADULT; ARTICLE; AUGMENTATION INDEX; BODY TEMPERATURE; BRACHIAL ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FOREARM BLOOD FLOW; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; VACCINATION; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; ARTERIAL STIFFNESS; BLOOD; BLOOD FLOW; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECT; FOREARM; IMMUNOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SALMONELLA TYPHI; TIME; VASCULARIZATION;

ACETYLCHOLINE; ADULT; BIOLOGICAL MARKERS; BODY TEMPERATURE; BRACHIAL ARTERY; CROSS-OVER STUDIES; ENDOTOXINS; FOREARM; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INFUSIONS, INTRA-ARTERIAL; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; NITROPRUSSIDE; PLETHYSMOGRAPHY; PULSE WAVE ANALYSIS; REGIONAL BLOOD FLOW; SALMONELLA TYPHI; SALMONELLA VACCINES; TIME FACTORS; VASCULAR STIFFNESS; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84871862254     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S19161     Document Type: Article

References (26)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Liuzzo G, Biassuci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
3. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
4. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
5. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and the risk of future myocardial infarction in apparently healthy men. Lancet. 1998;351: 88-92.
6. Werns SW, Walton JA, Hsaia HH, et al. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation. 1989;79:287-291.
7. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1906.
8. Perticone F, Ceravalo R, Puija A, et al. Prognostic significance of endothelial dysfuntion in hyptertensive patients. Circulation. 2001;104: 191-196.
9. Fischlscherer S, Rosenberger G, Walter DH, et al. Elevated C-reactive protein and impaired vasoreactivity in patients with coronary artery disease. Circulation. 2000;102:1000-1006.
10. Holmlund A, Hulthe J, Millgard J, Sarabi M, Kahan T, Lind L. Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals. Atherosclerosis. 2002;165:271-276.
11. Lima DS, Sato EI, Lima VC, et al. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2002;29:292-297.
12. Filer AD, Gardner-Medwin JM, Thambyrajah J, et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis. 2003;62:162-167.
13. Hürlimann D, Forster A, Noll G, et al. Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106:2184-2187.
14. Raza K, Thambyrajah J, Townend JN, et al. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation. 2000;102:1470-1472.
15. Bergholm R, Leirisalo-Repo M, Vehkavaara S, et al. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol. 2002;22:1637-1641.
16. Hingorani AD, Cross, J, Kharbanda RK, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994-999.
17. Pleiner J, Heere-Ress E, Langenberger H, et al. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol. 2002; 22:95-100.
18. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar M. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434-438.
19. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
20. Vlachopoulos C, Dima I, Aznaouridis K, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005;112:2193-2200.
21. Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension. 2004;44:112-116.
22. Peters TS, Lewis SJ. Lipopolysaccharide inhibits acetylcholine and nitric oxide-mediated vasodilation in vivo. J Pharmacol Exp Ther. 1996;279:918-925.
23. Pleiner J, Mittermayer F, Schaller G, et al. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation. 2002;106:1460-1464.
24. Kharbanda RK, Walton B, Allen M, et al. Prevention of inflammation-induced endothelial dysfunction. A novel vasculoprotective action of aspirin. Circulation. 2002;105:2600-2604.
25. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 1997;96: 3042-3047.
26. Pleiner J, Schaller G, Mittermayer F, et al. Simvastatin prevents vascular hyporeactivity during inflammation. Circulation. 2004;110:3349-3354.